Company intelligence / Profile preview
Fannin Innovation Studio
- Ownership
- Private
- Development stage
- Other
Overview
Fannin Innovation Studio advances a diverse pipeline of early-stage pharmaceutical and medical device programs addressing significant unmet needs. Three programs are in clinic, including pivotal-stage trials for heart failure and advanced clinical studies for immune modulation and monoclonal antibodies. Pipeline breadth includes at least a dozen active assets, encompassing proprietary therapeutics and medical technologies.[1][2][3][4]
- Therapeutic areas
- CardiovascularImmunologyNeurologyInfectious DiseasesOtherOncology
- Modalities
- Small moleculeMonoclonal antibodyDeviceBiologicPoint-of-care diagnosticNanoparticle
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Fannin Innovation Studio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fannin Innovation Studio.